UC TUR.WAR.OP.END. CEC/ DE000HD4QM30 /
6/14/2024 11:47:09 AM | Chg.-0.0800 | Bid1:35:10 PM | Ask1:35:10 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.1500EUR | -6.50% | 1.1400 Bid Size: 30,000 |
1.1500 Ask Size: 30,000 |
CECONOMY AG INH O.N... | 2.0761 - | 12/31/2078 | Call |
GlobeNewswire
1:30 PM
JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Note...
GlobeNewswire
1:30 PM
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evalua...
GlobeNewswire
1:30 PM
Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective an...
GlobeNewswire
1:30 PM
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Associatio...
GlobeNewswire
1:30 PM
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Associatio...
GlobeNewswire
1:14 PM
Hymson Brings its Laser Solutions for Battery Innovation to The Battery Show Europe 2024
GlobeNewswire
1:01 PM
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 V...
GlobeNewswire
1:00 PM
Correction: 仙境传说:破晓 (Ragnarok: Dawn, Tentative English Title) Received an ISBN from the Chinese Gove...
GlobeNewswire
1:00 PM
Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-3...
GlobeNewswire
1:00 PM
Volvo Car Canada Collaborates with iconic global fashion brand to unveil curated looks inspired by t...
GlobeNewswire
1:00 PM
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter ...
GlobeNewswire
1:00 PM
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in ...
GlobeNewswire
1:00 PM
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatmen...
GlobeNewswire
12:59 PM
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit